COLLAT-COVID: Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

Sponsor

Hospices Civils de Lyon (Other)

Overall Status

Recruiting

CT.gov ID

NCT05932719

Collaborator

(none)

4,000

Enrollment

Location

Anticipated Duration (Months)

166.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments).

Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.

Condition or Disease	Intervention/Treatment	Phase
Hepatocellular Carcinoma Peritoneal Carcinoma	Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

Study Design

Study Type:

Observational

Anticipated Enrollment :

4000 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators to Follow-up the Activities of Different Cancer Pathologies

Actual Study Start Date :

Dec 1, 2022

Actual Primary Completion Date :

Dec 1, 2022

Anticipated Study Completion Date :

Dec 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
Peritoneal Carcinosis Patients hospitalized for peritoneal carcinosis between 2017 and 2020.	Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files. The following items will be collected Diagnostic date Diagnostic stage Date of surgery Date of surgery appointment First antineoplastic treatment date Last antineoplastic treatment date Number of treatment cycles recommanded by MDTM
Hepatocellular Carcinoma Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.	Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files. The following items will be collected Diagnostic date Diagnostic stage Date of surgery Date of surgery appointment First antineoplastic treatment date Last antineoplastic treatment date Number of treatment cycles recommanded by MDTM

Arm

Intervention/Treatment

Peritoneal Carcinosis

Patients hospitalized for peritoneal carcinosis between 2017 and 2020.

Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

The following items will be collected Diagnostic date Diagnostic stage Date of surgery Date of surgery appointment First antineoplastic treatment date Last antineoplastic treatment date Number of treatment cycles recommanded by MDTM

Hepatocellular Carcinoma

Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.

Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

Outcome Measures

Primary Outcome Measures

Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019) [24 months]
The difference between a set of different activity indicators will be compared between 2020 and the average activities of previous periods (2017-2019)